(Q33924596)

30 July 2017

title

Management of malignant pleural effusions. (English)

1 reference

American Thoracic Society

30 July 2017

author

series ordinal

1

object named as

American Thoracic Society

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

162

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1987-2001

1 reference

Breast cancer complicated by pleural effusion: patient characteristics and results of surgical management

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Metastatic pattern at autopsy in non-resectable adenocarcinoma of the lung--a study from a cohort of 259 consecutive patients treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Breast carcinoma: Pattern of metastasis at autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Metastatic carcinoma of the pleura

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural diseases related to metastatic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Magnetic resonance (MR) imaging of the chest: state-of-the-art

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural effusions: the diagnostic separation of transudates and exudates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

The serum-effusion albumin gradient in the evaluation of pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Diagnostic utility of pleural fluid eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Malignant pleural effusions: meaning of pleural-fluid pH determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

High amylase levels in neoplasm-related pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

The diagnostic and therapeutic utility of thoracoscopy. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopy--state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopy for the diagnosis of pleural disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopy in the diagnosis of pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

The so-called malignant pleural effusion: a new review of direct data obtained with diagnostic pleuroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural effusion. A diagnostic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural effusion: laboratory tests in 300 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Effect of thoracentesis on pulmonary gas exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Effect of Thoracentesis on Arterial Oxygen Tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Hypoxemia after thoracentesis. A predictable and treatable condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Chemical pleurodesis for malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleurodesis using talc slurry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleurodesis with iodized talc for malignant effusions using pigtail catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Talc pleurodesis through small-bore percutaneous tubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Talc pleurodesis for the treatment of pneumothorax and pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Lung function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage or simple drainage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Respiratory failure following talc pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

The Significance of a Cytologically Negative Pleural Effusion in Bronchogenic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Natural history and epidemiology of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Diagnosis and management of malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Chemotherapy in malignant pleural mesothelioma. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Management of pleural effusions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural effusion in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleuroperitoneal shunts in the management of persistent chylothorax

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Pleural Effusion Due to Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

Fiberoptic Bronchoscopy and Pleural Effusion of Unknown Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.5.ATS8-00

10.1164/AJRCCM.162.5.ATS8-00

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference